Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.contributor | Universidade Estadual Paulista (Unesp) | - |
Autor(es): dc.contributor | Federal University of Mato Grosso (UFMT) | - |
Autor(es): dc.creator | de Souza, Sérgio Luiz Borges [UNESP] | - |
Autor(es): dc.creator | Mota, Gustavo Augusto Ferreira [UNESP] | - |
Autor(es): dc.creator | Gregolin, Cristina Schmitt | - |
Autor(es): dc.creator | do Nascimento, Milena | - |
Autor(es): dc.creator | Luvizotto, Renata Azevedo Melo | - |
Autor(es): dc.creator | Bazan, Silmeia Garcia Zanati [UNESP] | - |
Autor(es): dc.creator | Sugizaki, Mário Mateus | - |
Autor(es): dc.creator | Barbisan, Luis Fernando [UNESP] | - |
Autor(es): dc.creator | Cicogna, Antonio Carlos [UNESP] | - |
Autor(es): dc.creator | do Nascimento, André Ferreira | - |
Data de aceite: dc.date.accessioned | 2022-02-22T00:30:01Z | - |
Data de disponibilização: dc.date.available | 2022-02-22T00:30:01Z | - |
Data de envio: dc.date.issued | 2020-12-11 | - |
Data de envio: dc.date.issued | 2020-12-11 | - |
Data de envio: dc.date.issued | 2019-12-31 | - |
Fonte completa do material: dc.identifier | http://dx.doi.org/10.1007/s12265-020-09997-0 | - |
Fonte completa do material: dc.identifier | http://hdl.handle.net/11449/200270 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/11449/200270 | - |
Descrição: dc.description | Cirrhotic cardiomyopathy is a condition where liver cirrhosis is associated with cardiac dysfunction. Triggers and blockers of cirrhotic cardiomyopathy are poorly understood, which might compromise the prognosis of chronic liver disease patients. We tested whether exercise training would reduce liver damage induced by thioacetamide and prevent liver cirrhosis-associated cardiomyopathy. Wistar rats were divided into three groups: control, thioacetamide (TAA), or TAA plus exercise. Thioacetamide increased liver weight and serum alanine aminotransferase and aspartate aminotransferase levels. Also, TAA treatment was involved with hepatic nodule formation, fibrotic septa, inflammatory infiltration, and hepatocyte necrosis. The exercise group presented with a reduction in liver injury status. We found that liver injury was associated with disordered cardiac hypertrophy as well as diastolic and systolic dysfunction. Exercise training attenuated cirrhosis-associated cardiac remodeling and diastolic dysfunction and prevented systolic impairment. These results provided insights that exercise training can mitigate cirrhotic cardiomyopathy phenotype. [Figure not available: see fulltext.]. | - |
Descrição: dc.description | Department of Internal Medicine Botucatu School of Medicine São Paulo State University (UNESP), Botucatu | - |
Descrição: dc.description | Institute of Health Sciences Federal University of Mato Grosso (UFMT), Avenida Alexandre Ferronato, n°1200, Setor Industrial | - |
Descrição: dc.description | Department of Morphology Institute of Biosciences Sao Paulo State University (UNESP) | - |
Descrição: dc.description | Department of Internal Medicine Botucatu School of Medicine São Paulo State University (UNESP), Botucatu | - |
Descrição: dc.description | Department of Morphology Institute of Biosciences Sao Paulo State University (UNESP) | - |
Idioma: dc.language | en | - |
Relação: dc.relation | Journal of Cardiovascular Translational Research | - |
???dc.source???: dc.source | Scopus | - |
Palavras-chave: dc.subject | Cardiac dysfunction | - |
Palavras-chave: dc.subject | Cirrhotic cardiomyopathy | - |
Palavras-chave: dc.subject | Exercise training | - |
Palavras-chave: dc.subject | Liver cirrhosis | - |
Palavras-chave: dc.subject | Thioacetamide | - |
Título: dc.title | Exercise Training Attenuates Cirrhotic Cardiomyopathy | - |
Tipo de arquivo: dc.type | livro digital | - |
Aparece nas coleções: | Repositório Institucional - Unesp |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: